Hemp derived cannabinoid blends are becoming increasingly popular among those seeking relief from a variety of ailments and conditions. Cannabinoid blends are combinations of various cannabinoids that may have the potential to provide more effective relief than any single cannabinoid alone. The most common and well-known cannabinoid blends include Delta 8, Delta 10, HHC, THCP and THCV.
Delta 8 THC is an analogue of THC (tetrahydrocannabinol), the primary psychoactive compound in cannabis. This means that it has similar effects to THC but is produced through a different chemical reaction. The main difference between Delta 8 and Delta 9 (the traditional form of THC found in marijuana) is that Delta 8 binds to CB1 receptors with greater affinity than Delta 9, meaning it produces a slightly milder high. This makes it an attractive option for people looking for the benefits of cannabis without quite so much intoxication.
Delta 10 THC is another analog of THC that provides users with a milder and less intoxicating high than its traditional counterpart. Like Delta 8, this cannabinoid binds to the CB1 receptor in the brain but does so with greater affinity than even Delta 8 does. Some research suggests that this might make it especially effective for managing pain, inflammation and nausea; however further research needs to be done before any definitive conclusions can be drawn.
HHC (Hexahydrocannabinol) is a non-psychoactive cannabinoid found in cannabis plants that can produce analgesic effects by binding to both CB1 and CB2 receptors in the human body. It has been studied for its potential anti-inflammatory properties as well as its ability to reduce anxiety levels in humans. In addition, some evidence suggests that HHC may have neuroprotective properties which could help protect against degenerative neurological diseases such as Parkinson’s or Alzheimer’s disease.
THCP (Tetrahydrocannabiphorol) is another non-psychoactive cannabinoid found in cannabis plants that has recently been studied for its therapeutic potential. While research into THCP is still relatively new, early studies suggest it could offer users better pain relief than even traditional forms of THC due to its increased binding affinity at both CB1 and CB2 receptors located throughout the body. In addition, some researchers believe THCP may have neuroprotective properties similar to those observed with HHC though further study is necessary before any definite conclusions can be made on this matter.
Lastly there’s THVC (Tetrahydrocannabivarin), which functions similarly to regular THC but has been found to produce more sedative effects when used medicinally rather than an intoxicating high like regular THC does when used recreationally. Additionally some research suggests it may possess anticonvulsant properties which could make it useful for treating seizures associated with certain medical conditions such as epilepsy or Dravet Syndrome.
